Medicaid provides health coverage for disabled and low-income populations, and the ACA expansion gives states the option to extend coverage to adults with up to 138% of the federal poverty line.

ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV. But during a recent visit, the ...

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a form of HIV prevention, seven participants contracted the virus despite receiving their ...

Carl Schmid shares insight on the use of advocacy groups to help patients overcome barriers to access for HIV PrEP therapy. Ryan Haumschild, PharmD, MS, MBA: Before we conclude, I do want to ...

Share on Pinterest Research finds a new injectable form of PrEP is superior to daily oral tablets to prevent the contraction of HIV. Sara Jurado/Getty Images New research sheds light on the efficacy ...

A little specificity would go a long way in the recommendations of the US Preventive Services Task Force (USPSTF)—that is, if we want health insurance companies to pay for lifesaving HIV prevention ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the delivery of first shipments of lenacapavir – Gilead’s twice-yearly ...

A Jacobs School of Medicine and Biomedical Sciences faculty member is senior author on a newly published study on the public health challenges of HIV in Nigeria.

Nearly one in three gay and bisexual men who were diagnosed with HIV at UK sexual health clinics didn't meet the criteria for "high risk" that would signal to a clinician that they would be good ...